(Q53216635)

12 May 2018

title

The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients. (English)

1 reference

12 May 2018

2

H Soininen

1 reference

12 May 2018

P Riekkinen

1

1 reference

12 May 2018

J Partanen

3

1 reference

12 May 2018

A Pääkkönen

4

1 reference

12 May 2018

S Helisalmi

5

1 reference

12 May 2018

P Riekkinen

6

1 reference

12 May 2018

publication date

1 February 1997

1 reference

12 May 2018

published in

Psychopharmacology

1 reference

12 May 2018

volume

129

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

285-288

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s002130050192

exact match

0 references

cites work

Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Cholinergic deficit in Alzheimer's disease: A study based on CSF and autopsy data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

The cholinergic system and EEG slow waves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Effect of alpha2 antagonists and an agonist on EEG slowing induced by scopolamine and lesion of the nucleus basalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

Nicotine and tetrahydroaminoacradine: Evidence for improved attention in patients with dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002130050192

An indirect cholinesterase inhibitor, metrifonate, increases neocortical EEG arousal in rats.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9084068

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Quantitative EEG: I. Techniques and problems of frequency analysis and topographic mapping

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9084068

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S002130050192

1 reference

12 May 2018

PubMed ID

9084068

1 reference

12 May 2018